Junko Okabe‐Kado

2.2k total citations
90 papers, 2.0k citations indexed

About

Junko Okabe‐Kado is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Junko Okabe‐Kado has authored 90 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 26 papers in Hematology and 14 papers in Organic Chemistry. Recurrent topics in Junko Okabe‐Kado's work include Mechanisms of cancer metastasis (26 papers), Acute Myeloid Leukemia Research (22 papers) and Retinoids in leukemia and cellular processes (14 papers). Junko Okabe‐Kado is often cited by papers focused on Mechanisms of cancer metastasis (26 papers), Acute Myeloid Leukemia Research (22 papers) and Retinoids in leukemia and cellular processes (14 papers). Junko Okabe‐Kado collaborates with scholars based in Japan and Germany. Junko Okabe‐Kado's co-authors include Yoshio Honma, Takashi Kasukabe, Motoo Hozumi, Nozomi Niitsu, Moriaki Hayashi, Yasuhiko Kaneko, Yuri Yamamoto-Yamaguchi, Nobuo Kato, Yoshio Honma and Nobuo Maseki and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Junko Okabe‐Kado

89 papers receiving 1.9k citations

Peers

Countries citing papers authored by Junko Okabe‐Kado

Since Specialization

Citations

This map shows the geographic impact of Junko Okabe‐Kado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Okabe‐Kado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Okabe‐Kado more than expected).

Fields of papers citing papers by Junko Okabe‐Kado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Okabe‐Kado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Okabe‐Kado. The network helps show where Junko Okabe‐Kado may publish in the future.

Co-authorship network of co-authors of Junko Okabe‐Kado

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Okabe‐Kado. A scholar is included among the top collaborators of Junko Okabe‐Kado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Okabe‐Kado. Junko Okabe‐Kado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells 2018 ·Leukemia Research ·Junko Okabe‐Kado, (unknown), Nozomi Niitsu, Takashi Kasukabe, Yasuhiko Kaneko	7
2	Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells 2016 ·Oncology Reports ·Takashi Kasukabe, Yoshio Honma, Junko Okabe‐Kado, Yusuke Higuchi, Nobuo Kato, Shunichi Kumakura	83
3	Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells 2010 ·International Journal of Hematology ·Yuki Hagiwara, Takashi Kasukabe, Yasuhiko Kaneko, Nozomi Niitsu, Junko Okabe‐Kado	48
4	Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells 2009 ·Cancer Science ·Junko Okabe‐Kado, Takashi Kasukabe, Yoshio Honma, Hirofumi Kobayashi, Nobuo Maseki, Yasuhiko Kaneko	26
5	Physiological and Pathological Relevance of Extracellular NM23/NDP Kinases 2003 ·Journal of Bioenergetics and Biomembranes ·Junko Okabe‐Kado, (unknown)	18
6	Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma 2003 ·Leukemia ·Nozomi Niitsu, Yoshio Honma, Kimiko Iijima, Toshiyuki Takagi, M Higashihara, Umihiko Sawada, Junko Okabe‐Kado	20
7	Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome 2002 ·Leukemia ·Yoshikazu Ito, Junko Okabe‐Kado, Yoshio Honma, Osamu Iwase, Takashi Shimamoto, J H Ohyashiki, Kazuma Ohyashiki	3
8	Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes 2002 ·Experimental Hematology ·Tsuyoshi Nakamaki, Junko Okabe‐Kado, Yuri Yamamoto-Yamaguchi, (unknown), Shigeru Tomoyasu, Yoshio Honma, Takashi Kasukabe	24
9	Serum nm23-H1 Protein as a Prognostic Factor in Hematological Malignancies 2002 ·Leukemia & lymphoma ·Junko Okabe‐Kado	27
10	Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives 2001 ·Experimental Hematology ·Yoshio Honma, Yuki Ishii, Takashi Kasukabe, Junko Okabe‐Kado, (unknown), Tomohito Kakegawa, Akira Awaya	4
11	Anticancer Derivative of Butyric Acid (Pivalyloxymethyl Butyrate) Specifically Potentiates the Cytotoxicity of Doxorubicin and Daunorubicin through the Suppression of Microsomal Glycosidic Activity 2000 ·Molecular Pharmacology ·Nozomi Niitsu, Takashi Kasukabe, Akihiro Yokoyama, Junko Okabe‐Kado, Yuri Yamamoto-Yamaguchi, Masanori Umeda, Yoshio Honma	29
12	Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hop 1998 ·Leukemia Research ·Yoshio Honma, Hiroyasu Tobe, Makoto Makishima, Akihiro Yokoyama, Junko Okabe‐Kado	24
13	Identity of Human Normal Counterpart (MmTRA1b) of Mouse Leukemogenesis-Associated Gene (MmTRA1a) Product as Plasma Membrane Phospholipid Scramblase and Chromosome Mapping of the Human MmTRA1b/Phospholipid Scramblase Gene 1998 ·Biochemical and Biophysical Research Communications ·Takashi Kasukabe, Hirofumi Kobayashi, Yasuhiko Kaneko, Junko Okabe‐Kado, Yoshio Honma	20
14	Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells 1995 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Junko Okabe‐Kado, Takashi Kasukabe, Hideo Baba, Takeshi Urano, Hiroshi Shiku, Yoshio Honma	35
15	Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes. 1994 ·PubMed ·Takashi Kasukabe, Junko Okabe‐Kado, Motoo Hozumi, Yoshio Honma	13
16	Inhibition of abl Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells 1990 ·Japanese Journal of Cancer Research ·Yoshio Honma, Junko Okabe‐Kado, Takashi Kasukabe, Motoo Hozumi, Kazuo Umezawa	54
17	Inhibitory Action of Transforming Growth Factor‐β on Induction of Differentiation of Myeloid Leukemia Cells 1989 ·Japanese Journal of Cancer Research ·Junko Okabe‐Kado, Yoshio Honma, Moriaki Hayashi, Motoo Hozumi	8
18	Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells 1989 ·Cancer Immunology Immunotherapy ·Togo Ikuta, Yoshio Honma, Junko Okabe‐Kado, Takashi Kasukabe, Motoo Hozumi	4
19	Induction of Differentiation of Mouse Myeloid Leukemia M1 Cells by Serum of Patients with Chronic Myeloid Leukemia 1988 ·Japanese Journal of Cancer Research ·Junko Okabe‐Kado, Yoshio Honma, Moriaki Hayashi, Motoo Hozumi, K Sampi, Masaharu Sakurai, (unknown), Nobuyoshi Tsuruoka	3
20	Establishment and characterization of a polyploid mouse myeloid leukemia cell line useful for in-vivo examination of cell proliferation kinetics 1987 ·Leukemia Research ·Moriaki Hayashi, Junko Okabe‐Kado, Motoo Hozumi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact